Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advanced MRI for TIME in Glioblastoma
NCT07461948Phase 3Recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Oct 2025
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoints: Mean diffusion-relaxation correlation spectrum imaging value, Ferumoxytol-enhanced magnetic resonance imaging measures and 1 more. Started Oct 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07461948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07461948.